Friday, December 11, 2015

Roche gets accelerated U.S. approval for lung cancer drug

… 's drug for advanced lung cancer in patients with a specific … with advanced ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)